Metadata

Name CCU002_02 Hypercholesterolaemia
Type Disease or Syndrome
Group Disease or Syndrome
Data Sources




Clinical Terminologies SNOMED-CT
Codelists covid_impact_ccu00202_hypercholesterolaemia_England_SNOMEDCT.csv
Valid Event Data Range 08/12/2020 - 18/03/2021
Sex Female
Male
Authors CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow
Agreement Date 23 Aug 2021
Version (UUID) Revision 1 (COVID-IMPACT)

Phenotypes

Code type is set to 1 for incident events, and 0 for prevalent events.

England primary care EHR: Hypercholesterolaemia diagnosis

terminology code term code_type
SNOMEDCT 166831007 Serum cholesterol very high 1.0
SNOMEDCT 238077000 Polygenic hypercholesterolaemia 1.0
SNOMEDCT 267432004 Pure hypercholesterolaemia 1.0
SNOMEDCT 397915002 Fredrickson type IIa hyperlipoproteinemia (disorder) 1.0
SNOMEDCT 398036000 Familial hypercholesterolemia (disorder) 1.0
SNOMEDCT 238038003 Familial hyperlipoproteinemia (disorder) 1.0
SNOMEDCT 238040008 Familial combined hyperlipidemia (disorder) 1.0
SNOMEDCT 238076009 Primary hypercholesterolemia (disorder) 1.0
SNOMEDCT 238078005 Familial hypercholesterolemia - homozygous (disorder) 1.0
SNOMEDCT 238079002 Familial hypercholesterolemia - heterozygous (disorder) 1.0
SNOMEDCT 238086005 Fredrickson type I hyperlipoproteinemia (disorder) 1.0
SNOMEDCT 34349009 Familial type 5 hyperlipoproteinemia (disorder) 1.0
SNOMEDCT 34528009 Familial hypertriglyceridemia (disorder) 1.0
SNOMEDCT 398796005 Familial type 3 hyperlipoproteinemia (disorder) 1.0
SNOMEDCT 403829002 Familial hypercholesterolemia due to heterozygous low density lipoprotein receptor mutation (disorder) 1.0
SNOMEDCT 190773008 Hyperbetalipoproteinemia (disorder) 1.0
SNOMEDCT 190774002 Hyperlipidemia, group A (disorder) 1.0
SNOMEDCT 238081000 Familial defective apolipoprotein B-100 (disorder) 1.0
SNOMEDCT 238083002 Primary hypertriglyceridemia (disorder) 1.0
SNOMEDCT 238088006 Primary combined hyperlipidemia (disorder) 1.0
SNOMEDCT 267434003 Mixed hyperlipidemia (disorder) 1.0
SNOMEDCT 267435002 Familial hyperchylomicronemia (disorder) 1.0
SNOMEDCT 33513003 Familial apolipoprotein C-II deficiency (disorder) 1.0
SNOMEDCT 403830007 Familial hypercholesterolemia due to homozygous low density lipoprotein receptor mutation (disorder) 1.0
SNOMEDCT 403831006 Familial hypercholesterolemia due to genetic defect of apolipoprotein B (disorder) 1.0
SNOMEDCT 445010006 Low density lipoprotein receptor mutation (disorder) 1.0
SNOMEDCT 57218003 Cholesterol ester storage disease (disorder) 1.0
SNOMEDCT 867261000000106 Probable familial hypercholesterolaemia (situation) 1.0
SNOMEDCT 473145005 Possible familial hypercholesterolemia (situation) 1.0
SNOMEDCT 513831000000107 Possible heterozygous familial hypercholesterolaemia (situation) 1.0
SNOMEDCT 925211000000100 Familial hypercholesterolaemia targeted genetic test (procedure) 1.0

Publication

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England

CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow

medRxiv 2021.08.18.21262222; doi: https://doi.org/10.1101/2021.08.18.21262222